Z-3129-2026 Class I Ongoing
Recalled by Nova Biomedical Corporation
— Waltham, MA
FDA device recall Z-3129-2026 was initiated by Nova Biomedical Corporation on Jul 29, 2026 and is designated Class I. Reason for recall: A software synchronization/timing issue in the barcode scanning and patient data processing component that causes the device to intermittently retain a previously scanned barcode including patient… The recall status is ongoing. Affected quantity: 10,941 units.
Recall details
- Product Type
- Devices
- Report Date
- Sep 23, 2026
- Initiation Date
- Jul 29, 2026
- Voluntary/Mandated
- Voluntary: Firm initiated
- Product Quantity
- 10,941 units
Product description
StatStrip Glucose Hospital Meter System. Model No: 66739. Glucose test system.
Reason for recall
A software synchronization/timing issue in the barcode scanning and patient data processing component that causes the device to intermittently retain a previously scanned barcode including patient identification (ID) barcodes and quality control (QC) solution ID barcodes when a new barcode is scanned, resulting in the prior barcode information remaining displayed on the screen for the current test. When this defect occurs and the operator accepts the incorrectly displayed patient information without recognizing the mismatch, the current patient's glucose result will be incorrectly assigned to the previous patient's medical record and transmitted to the data management system (DMS), and the current patient's medical record will not receive a result, leaving their glucose status unrecorded and their clinical management without the information needed to guide treatment decisions. The previous patient, whose medical record now contains a glucose result that does not belong to them, may receive inappropriate clinical intervention based on that erroneous result, particularly in critically ill patients, neonates, and infants who cannot communicate symptoms or self-treat. The defect also affects QC barcode scanning: if a QC scan triggers the same retention behavior, QC results may be attributed to an incorrect identifier or QC tests may fail without the user recognizing the underlying cause. This defect does not affect the analytical accuracy of glucose measurements.
Distribution pattern
Worldwide distribution: US (nationwide) and OUS (foreign) countries of: Austria, Belgium, Bolivia, Brazil, Canada, Cayman Islands, Chile, Croatia, Dominican Rep., Finland, France, Germany, Ireland, Israel, Italy, Netherlands, New Zealand, South Korea, Switzerland, Thailand, Turkey, United Kingdom.
Code information
Model No: 66739. UDI-DI: 0038548063685. Software Versions: All versions 0.00.13.10 through 1.5.14.25.
Source
- Dataset
- openFDA device recall enforcement reports
- FDA record
- This recall in openFDA (JSON)
- Enforcement Report
- Search FDA's Enforcement Report for Z-3129-2026
- openFDA file date
- Nov 19, 2026
- Loaded by RegDataLab
- Nov 20, 2026
These dates say when openFDA published the data file and when RegDataLab last loaded it.
Need the full FDA record for Nova Biomedical Corporation? Ask Claude or ChatGPT with the RegDataLab connector and get every site's inspections, Form 483s, warning letters, recalls and import alerts, each with a link to the FDA source. The API key is free: no card.
Get a free API key
How the connector works